Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;52(12):5773-5787.
doi: 10.1080/03610918.2021.1999473. Epub 2021 Nov 15.

Optimal Personalized Treatment Selection with Multivariate Outcome Measures in a Multiple Treatment Case

Affiliations

Optimal Personalized Treatment Selection with Multivariate Outcome Measures in a Multiple Treatment Case

Chathura Siriwardhana et al. Commun Stat Simul Comput. 2023.

Abstract

In this work we propose a novel method for individualized treatment selection when there are correlated multiple treatment responses. For the K treatment (K ≥ 2) scenario, we compare quantities that are suitable indexes based on outcome variables for each treatment conditional on patient-specific scores constructed from collected covariate measurements. Our method covers any number of treatments and outcome variables, and it can be applied for a broad set of models. The proposed method uses a rank aggregation technique that takes into account possible correlations among ranked lists to estimate an ordering of treatments based on treatment performance measures such as the smooth conditional mean. The method has the flexibility to incorporate patient and clinician preferences into the optimal treatment decision on an individual case basis. A simulation study demonstrates the performance of the proposed method in finite samples. We also present data analyses using HIV clinical trial data to show the applicability of the proposed procedure for real data.

Keywords: Design variables; Personalized Treatments; Rank Aggregation; Single Index Models.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors have declared no conflict of interest.

Similar articles

References

    1. Murphy SA (2003), Optimal dynamic treatment regimes. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 65: 331–355. doi:10.1111/1467-9868.00389 - DOI
    1. van’t Veer LJ & Bernards R (2008). Enabling Personalized Cancer Medicine Through Analysis of Gene-Expression Patterns. Nature, 452: 564–570. - PubMed
    1. Zhao Y, Donglin Z, Rush AJ, and Kosorok MK (2012), “Estimating Individualized Treatment Rules Using Outcome Weighted Learning”, Journal of the American Statistical Association, pp. 1106–1118. - PMC - PubMed
    1. Vazquez A (2013). Optimization of Personalized Therapies for Anticancer Treatment. BMC Syst. Biol, 7: doi:10.1186/1752-0509-7-31. - DOI - PMC - PubMed
    1. Kosorok MR and Moodie EE (2015). Adaptive Treatment Strategies in Practice: Planning Trials and Analyzing Data for Personalized Medicine. Society for Industrial and Applied Mathematics, doi: 10.1137/1.9781611974188. - DOI

LinkOut - more resources